Intralytix receives a positive #LuxTake by Lux Research
Intralytix was given a "Positive" Lux Take by Lux Research in a recent report to Lux's subscribing member base.
"Intralytix continues to be one of the more advanced companies within the phage space, with a proven track record of commercializing products."
Lux Research is an independent research and advisory firm, that provides strategic advice and ongoing intelligence on emerging technologies to major corporate enterprises worldwide. Lux has been following Intralytix for several years. For more information about Lux Research and their insights, please visit their website: https://www.luxresearchinc.com/.
May 11, 2021